Hong Kong Wen Wei Po (Reporter Gao Yu) The 2017 National Science and Technology Awards was held in the Great Hall of the People in Beijing. The Chinese University has partnered with "The Establishment and Application of Preclinical Targeted Lung Cancer Therapy Models" and "Ischemic Stroke New Strategy and New Technology for Prevention and Control and Application of Popularization and Application "won the second prize of National Science and Technology Progress Award The achievements of the research studies in PolyU have been encouraging. Our researchers have brought forth significant improvements in people's lives. One of the best examples is PolyU's successful development of space tool..
Anti-cancer drug mechanism is expected to "no longer deadly"
Professor Mo Shujin, Department of Oncology, Department of Oncology, CUHK Medical School and Professor Wu Yilong, Guangdong Provincial People's Hospital led the research on lung cancer, especially for lung adenocarcinoma with epidermal growth factor receptor (EGFR) gene mutation and finally created "Targeted therapy" mode extends patient survival from 10 months to 22 months.
The team also found that EGFR secondary mutations in the formation of oncogenic factors can trigger cancer drug resistance mechanisms for patients with new gene mutations and drug resistance, the team found that the new precision treatment can be effectively extended its non-malignant survival More than doubled The research results are included in China and the world's guide to diagnosis and treatment of lung cancer. Mo Shujin expected future lung cancer can no longer be a deadly disease, but a chronic disease that can be treated with drugs.
Huang Jiaxing, an emeritus clinical professor of medicine and pharmacy at CUPL, is engaged in research on the prevention and treatment of stroke with the help of a team of specialists from the Third Military Medical University of Chinese People's Liberation Army and Chongqing Medical University. Huang Jiaxing, based on his study at the Prince of Wales Hospital, confirmed that cerebrovascular constriction is the major cause of stroke in Chinese. Dual antiplatelet therapy is more effective in reducing "transient ischemic" and mild Degree of micro-embolism in stroke patients.
Two new ways to improve stroke symptoms
In recent years, Wong's team has also found that "extra-corporeal counterpulsation" can improve cerebral blood flow in stroke patients. "Magnetoencephalitis" helps patients regain their mobility by reconnecting the damaged corpus with the brain. Wong Ka Sing said he hopes to bring about a new light to patients with stroke due to disability |
收藏
推
噓
